AR045369A1 - Composicion desbridante para heridas - Google Patents

Composicion desbridante para heridas

Info

Publication number
AR045369A1
AR045369A1 ARP040102915A ARP040102915A AR045369A1 AR 045369 A1 AR045369 A1 AR 045369A1 AR P040102915 A ARP040102915 A AR P040102915A AR P040102915 A ARP040102915 A AR P040102915A AR 045369 A1 AR045369 A1 AR 045369A1
Authority
AR
Argentina
Prior art keywords
spray
wounds
cps
composition
debriding composition
Prior art date
Application number
ARP040102915A
Other languages
English (en)
Original Assignee
Healthpoint Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthpoint Ltd filed Critical Healthpoint Ltd
Publication of AR045369A1 publication Critical patent/AR045369A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un spray atomizador desbridante de heridas en forma de tópico se prepara formando una niebla, un spray o espuma que no goteará significativamente después de la aplicación. La papaína es el desbridante de heridas preferido. El spray contiene una mezcla de emulsionante surfactante que tiene una viscosidad de la composición de aproximadamente 5.000 cps a 50.000 cps y es preferentemente una composición emulsionante de ésteres de fosfato de alcoholes grasos.
ARP040102915A 2003-08-13 2004-08-13 Composicion desbridante para heridas AR045369A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/639,991 US7785584B2 (en) 2003-08-13 2003-08-13 Ointment wound spray

Publications (1)

Publication Number Publication Date
AR045369A1 true AR045369A1 (es) 2005-10-26

Family

ID=34135992

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102915A AR045369A1 (es) 2003-08-13 2004-08-13 Composicion desbridante para heridas

Country Status (6)

Country Link
US (2) US7785584B2 (es)
KR (1) KR20060032657A (es)
AR (1) AR045369A1 (es)
CA (1) CA2535343A1 (es)
TW (1) TW200507883A (es)
WO (1) WO2005018695A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
WO2005032521A2 (en) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
US20050281806A1 (en) * 2004-06-16 2005-12-22 Collegium Pharmaceutical, Inc., Delaware Compositions for topical enzymatic debridement
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
EP2108360A3 (en) * 2005-10-24 2010-06-09 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
CA2634045C (en) * 2005-12-20 2019-05-07 Swiss-American Products, Inc. Protease compositions for the treatment of damaged tissue
US8754045B2 (en) 2006-05-12 2014-06-17 James A. Livingston Enzymatic debridement therapy for abnormal cell proliferation
US7288622B1 (en) 2006-09-19 2007-10-30 Issar Pharmaceuticals Pvt Ltd Composition for treatment of burns and wounds
WO2008088756A1 (en) * 2007-01-12 2008-07-24 Bridge Pharma, Inc. Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
US20090053337A1 (en) * 2007-08-21 2009-02-26 L'oreal Composition and method of improving skin barrier function of compromised skin
US8808259B2 (en) 2007-11-21 2014-08-19 T.J. Smith & Nephew Limited Suction device and dressing
HUE049431T2 (hu) 2007-11-21 2020-09-28 Smith & Nephew Sebkötözés
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
JP5684725B2 (ja) 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
ES2727746T3 (es) 2009-01-06 2019-10-18 Galenagen Llc Composiciones orales para el tratamiento o la prevención de infecciones por E. Coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
BR112012013812A2 (pt) * 2009-12-08 2018-05-29 Healthpoint Ltd "composições para desbridamento enzimático de feridas com atividade enzimática melhorada"
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
US20130245716A1 (en) * 2010-04-29 2013-09-19 Tufts University Sleeve for stimulation of tissue regeneration
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
CA2819032C (en) 2010-11-25 2020-06-23 Smith & Nephew Plc Composition i-ii and products and uses thereof
WO2012145651A2 (en) 2011-04-21 2012-10-26 Curemark, Llc Compounds for the treatment of neuropsychiatric disorders
EP2707019B1 (en) 2011-05-12 2016-06-29 Smith & Nephew Orthopaedics AG Wound debridement compositions containing seaprose and methods of wound treatment using same
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
CA2862363C (en) * 2012-02-02 2021-06-08 Joan M. Fallon Enzyme compositions and use thereof for wound healing
MX2014013745A (es) 2012-05-11 2016-05-05 Smith & Nephew Inc Uso de seaprose para eliminar la pelicula biologica bacteriana.
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
WO2014078581A1 (en) 2012-11-14 2014-05-22 Smith & Nephew, Inc. Stable thermolysin hydrogel
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
WO2016094675A1 (en) 2014-12-12 2016-06-16 Smith & Nephew, Inc. Use of clostridium histolyticum protease mixture in promoting wound healing
US9999677B1 (en) * 2015-03-07 2018-06-19 Connie D. Starns Wound healing composition
US11628207B2 (en) 2016-07-27 2023-04-18 Smith & Nephew, Inc. Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
WO2018140707A1 (en) 2017-01-30 2018-08-02 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce eliminate bacterial biofilms from surfaces
CN111372595A (zh) * 2017-11-21 2020-07-03 塔普克斯制药公司 治疗皮肤的方法和组合物
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1503373A (en) * 1923-06-30 1924-07-29 Herschel G Parker Funnel
US2917433A (en) * 1956-04-02 1959-12-15 Rystan Company Stable aqueous papain topical compositions
US3804134A (en) * 1972-08-17 1974-04-16 Continental Oil Co Collapsible funnel for dispensing liquids from puncturable containers
US3983209A (en) * 1975-01-28 1976-09-28 Alza Corporation Method for treating burns
EP0015691B1 (en) * 1979-03-06 1984-05-30 Hercules Incorporated Microbial polysaccharide, its preparation and use
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
SE427680B (sv) * 1981-10-01 1983-04-25 Oscar Sven Arntyr Anordning for avskiljning och uppsamling av fororeningar vid dagvattenbrunnar
US4443964A (en) * 1981-10-09 1984-04-24 Albany International Corp. Insect trap
US4557378A (en) * 1983-11-22 1985-12-10 Klebold Franklin R Combination collapsible funnel and canister therefor
US4612914A (en) * 1984-05-07 1986-09-23 Dogey Kent A Portable collapsible solar survival apparatus
US4668228A (en) 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
US4592163A (en) * 1985-06-28 1986-06-03 Mebane Packaging Corporation Telescoping carton and insect trap
GB8925473D0 (en) * 1989-11-10 1989-12-28 Unilever Plc Sunscreen compositions
JP2863946B2 (ja) * 1990-04-13 1999-03-03 株式会社コーセー 化粧料
US5121779A (en) * 1990-12-31 1992-06-16 John Green Funnel
EP0498532A1 (en) 1991-01-10 1992-08-12 E.R. SQUIBB & SONS, INC. Necrotic tissue debridement powder composition containing a proteolytic enzyme
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
EP0606219A1 (en) * 1991-06-24 1994-07-20 Carrington Laboratories, Inc. Wound cleanser
IL105699A0 (en) 1992-06-26 1993-09-22 Genzyme Corp Hydrophilic creams for delivery of therapeutic agents
JP3591837B2 (ja) * 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
WO1995023614A1 (en) 1994-03-01 1995-09-08 E.R. Squibb & Sons, Inc. Enzymatic debridement compositions and methods
US5387517A (en) 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
EP0789619B1 (en) * 1994-11-04 2003-01-22 Croda, Inc. Fatty alcohol phosphate ester emulsifier compositions
US5536502A (en) * 1995-02-03 1996-07-16 Gerit D. Mulder Skin-tear medicament and method of use
US5565189A (en) 1995-02-03 1996-10-15 Mulder; Gerit D. Wound cleanser method of use
US5543149A (en) * 1995-03-01 1996-08-06 Rubin; Stan M. Treatment for insect bites
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
US5897539A (en) * 1995-09-28 1999-04-27 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
US5874476A (en) * 1997-07-14 1999-02-23 Rohm And Haas Company Dihaloformaldoxime carbamates as antimicrobial agents
US6046178A (en) * 1997-04-18 2000-04-04 Deroyal Industries, Inc. Method and compound for treating wounds with starch hydrolysate medication
US6017531A (en) 1997-06-02 2000-01-25 W. R. Grace & Co. Hydrophilic composition containing protease produced by Vibrio
US6222015B1 (en) * 1997-09-08 2001-04-24 Merck & Co., Inc. Estrogen receptor
US6039214A (en) * 1997-09-30 2000-03-21 Hewett; Frank W. Material dispensing system
KR20010041935A (ko) * 1998-03-16 2001-05-25 데이비드 엠 모이어 피부 외형을 조절하는 조성물
JP3294211B2 (ja) * 1999-02-02 2002-06-24 長野日本無線株式会社 スイッチング電源装置
US20020045600A1 (en) * 1999-07-08 2002-04-18 Schwarzman Laura M. Topical skin treatment for sea lice, insect bites and skin irritation
CA2379419A1 (en) * 1999-08-16 2001-02-22 Playtex Products, Inc. Sunscreen lotion or spray composition
US6315677B1 (en) * 2000-02-28 2001-11-13 David Sandlin Golf ball catching funnel
US6416769B1 (en) * 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof
GB2365330B (en) * 2000-08-04 2003-11-19 Glaser Alan Locking mechanism suitable for use in office type chairs
US6548556B2 (en) * 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
DE10100015A1 (de) 2001-01-02 2002-08-14 Vetcom Pharma Gmbh Sprühbare enzymhaltige Zusammensetzung
EP1247519A1 (de) 2001-04-06 2002-10-09 Cognis Deutschland GmbH & Co. KG Sprühbare Emulsionen
US6397907B1 (en) * 2001-07-27 2002-06-04 John E. Heintz Telescoping funnel apparatus
US6479060B1 (en) * 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods

Also Published As

Publication number Publication date
WO2005018695A1 (en) 2005-03-03
US20050036950A1 (en) 2005-02-17
KR20060032657A (ko) 2006-04-17
CA2535343A1 (en) 2005-03-03
TW200507883A (en) 2005-03-01
US7785584B2 (en) 2010-08-31
US20070003486A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
AR045369A1 (es) Composicion desbridante para heridas
WO2006129161A3 (en) Vitamin formulation
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
ES2152701T3 (es) Composiciones acuosas desinfectantes y de limpieza.
TW200626203A (en) Method for spraying a medium and spraying nozzle
HN2001000008A (es) Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
CO6650344A2 (es) Aceites microencapsulados para controlar la deriva de las atomizaciones de plaguicidas
MXPA02006895A (es) Metodos y aparatos para dispersar una substancia.
PA8497901A1 (es) Sistemas y metodos para aerosolizar formulaciones farmaceuticas.
PA8485501A1 (es) Formulaciones antiparasitarias
AR040305A1 (es) Vendaje hemostatico para heridas que contiene un polisacarido modificado con aldehido y agentes hemostaticos
AR044963A1 (es) Aparato y metodo para recubrir microproyecciones de perforacion de la piel
AR034660A1 (es) Nebulizador para la aplicacion de liquidos sobre la cornea del ojo
NO962994D0 (no) Framgangsmåte for framstilling av hule mikrosfærer
WO2014210461A4 (en) Emanation system and method for use
EA201070701A1 (ru) Способ и устройство для получения аэрозоля
WO2004018553A3 (en) Methods for preparing ethers, halogenated ethers, fluoroethers as well as uses of the latter in fire extinguishing systems.
DE60221112D1 (de) Folienzusammensetzung zur lokalen anwendung und verwendung zur freisetzung von aktivstoffen
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
MX2021005117A (es) Formulacion aerosolizable.
ATE376834T1 (de) Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase
DE50312948D1 (de) Alicyclische ester mit moschusgeruch
DE602004019521D1 (de) Sprühbare, fraktioniertes öl enthaltende zusammensetzung zur ablösung von nahrungsmitteln von kochwaren, sowie verfahren zur herstellung eines nahrungsmittels
DK2196090T3 (da) Virucidt desinfektionsmiddel

Legal Events

Date Code Title Description
FB Suspension of granting procedure